Rocket Pharmaceuticals Announces First Patient Treated in Phase 1 Trial of RP-L301 Gene Therapy for Pyruvate Kinase Deficiency

  • Jonathan Schwartz,

Press/Media

Period13 Jul 2020 → 14 Jul 2020

Media coverage

2

Media coverage

  • Title-Rocket Pharmaceuticals Announces First Patient Treated in Phase 1 Trial of RP-L301 Gene Therapy for Pyruvate Kinase Deficiency
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date14/07/20
    PersonsJonathan Schwartz,
  • TitleRocket Pharmaceuticals Announces First Patient Treated in Phase 1 Trial of RP-L301 Gene Therapy for Pyruvate Kinase Deficiency
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date13/07/20
    PersonsJonathan Schwartz,
View all 2
View less